These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8097786)

  • 1. Stimulation of brain dopamine autoreceptors by remoxipride administration in reserpine-treated male rats.
    Ahlenius S; Ericson E; Wijkström A
    J Pharm Pharmacol; 1993 Mar; 45(3):237-9. PubMed ID: 8097786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.
    Nissbrandt H; Engberg G; Wikström H; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):148-61. PubMed ID: 3141816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis.
    Tunnicliff G; Brokaw JJ; Hausz JA; Matheson GK; White GW
    Neuropharmacology; 1992 Oct; 31(10):991-5. PubMed ID: 1436392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A; Brotchie JM; Jones OT
    Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxytryptamine in various brain areas of the rat.
    Colado MI; Ormazabal MJ; Alfaro MJ; Martin MI
    J Pharm Pharmacol; 1993 Mar; 45(3):220-2. PubMed ID: 7683338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S; Hillegaart V; Wijkström A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):551-6. PubMed ID: 2570361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed agonist-antagonist properties of umespirone at neostriatal dopamine receptors in relation to its behavioral effects in the rat.
    Ahlenius S; Wijkström A
    Eur J Pharmacol; 1992 Nov; 222(1):69-74. PubMed ID: 1361441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat.
    Ahlenius S; Salmi P
    Eur J Pharmacol; 1994 Aug; 260(2-3):177-81. PubMed ID: 7988642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinpirole--a 5-HT receptor antagonist?
    Ahlenius S; Hillegaart V; Wijkström A
    Neurosci Lett; 1991 May; 126(1):57-9. PubMed ID: 1678151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
    Reches A; Wagner HR; Jackson-Lewis V; Fahn S
    Brain Res; 1985 Nov; 347(2):346-9. PubMed ID: 3933764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.
    Kehr W
    Eur J Pharmacol; 1984 Jan; 97(1-2):111-9. PubMed ID: 6421606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH; Rossetti ZL; Meloni M; Frau MI; Gessa GL
    Eur J Pharmacol; 1983 Aug; 91(4):463-8. PubMed ID: 6413231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
    Carlsson A; Kehr W; Lindqvist M
    J Neural Transm; 1977; 40(2):99-113. PubMed ID: 323424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
    Magnusson O; Fowler CJ; Mohringe B; Wijkström A; Ogren SO
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):379-84. PubMed ID: 2900472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
    Magnusson O; Mohringe B; Thorell G; Lake-Bakaar DM
    Pharmacol Toxicol; 1987 May; 60(5):368-73. PubMed ID: 2886989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.